期刊文献+

飞行时间质谱技术筛查上皮性卵巢癌患者血清特异性蛋白的研究

Serum Proteomic Patterns of Epithelial Ovarian Cancer by SELDI-TOF-MS
下载PDF
导出
摘要 目的:应用飞行时间质谱技术筛选上皮性卵巢癌患者与正常人血清中差异性蛋白,探讨蛋白质组学诊断模型用于上皮性卵巢癌的早期诊断的可行性。方法:应用弱阳离子芯片(WCX2)及表面增强激光解析电离飞行时间质谱仪(SELDI-TOF-MS)检测20例正常人(对照组)和40例上皮性卵巢癌(观察组)患者血清中的差异蛋白质,并检测差异蛋白筛选上皮性卵巢癌的特异性和敏感度。结果:对照组与观察组在1500~20000Da间,质荷比为3865Da、4318Da及5089Da的蛋白峰差异有统计学意义(P<0.05)。3个蛋白区分对照组与观察组的敏感性与特异性为80.00%(32/40)、85.00%(17/20)。结论:SELDI-TOF-MS技术对上皮性卵巢癌早期诊断具有一定价值。 Objective To detect the serum markers in epithelial ovarian cancer by SELDI-TOF-MS,and lay a foundation for the early screening. Methods Serum proteins of 20 healthy people and 40 cases with ovarian cancer were detected and compared by WCX2 chip and SELDI-TOF-MS. Results From 1 500 Da to 20 000 Da,the content of three proteins (3 865 Da,4 318 Da) had significant difference in the three groups.The sensitivity and specificity of the three proteins were 80.00% (32/40 and 85.00% (17/20). Conclusion SELDI-TOF-MS technology shows great potentiality for early diagnosis of ovarian cancer and specific tumor marker screening,and deserves generalization.
出处 《中国中西医结合外科杂志》 CAS 2009年第6期578-581,共4页 Chinese Journal of Surgery of Integrated Traditional and Western Medicine
关键词 上皮性卵巢癌 WCX2芯片 SELDI-TOF-MS技术 epithelial ovarian cancer weak cation exchanger protein chip SELDI-TOF-MS.
  • 相关文献

参考文献10

  • 1Conrads TP FusaroVA Ross Set al. High - resolution serum proteomic featuresfor ovarian cancer detection [ J ]. Endocr Rel at Cancer, 2004, 11 (2) 163.
  • 2Rai AJ , Gelfand CA , Haywood BC, et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples[J]. Proteomics ,2005 ,5 : ( 13)3262.
  • 3Wiesner A. Detection of ttwnor markers with protein chip technology[ J]. Curr Pharm Bio technol, 2004,5( 1 ) :45.
  • 4Conrads TP, Hood BL, Issaq HJ , et al. Proteomic patterns as a diagnostic tool for early - stage cancer : a review of it' s progress to a clinically relevant tool[J]. Mol Diagn ,2004,8(2) :77.
  • 5Sanders ME, Dias EC, Xu BJ, et al. Differentiating proteomic biomarkers in breast cancer by laser capture, microdissection and MALDI MS[J]. J Proteome Res, 2008,7 ( 4 ) : 1500.
  • 6Fleming K, Kelley LA , Islam SA , et al. The proteome: strucure function and evolution [ J ]. Philos Trans R Soc Lond B Biol Sci , 2006, 361 (1467) :441.
  • 7Moshkovskii SA , Serebryakova MV. Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid Al [ J ]. Proteomics, 2005,5 (14) :3790.
  • 8Martijn D , Roel JV , Ritsert CJ. SELDI - TOF mass spectra: A view on sources of variation[J]. J Chroma B, 2007,847( 1 ) : 12.
  • 9Moshkovskii SA , Serebryakova MV. Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid AI [J]. Proteomics, 2005 ,5 (14) :3790.
  • 10Rai AJ , Zhang Z, Rosenzweig J , et al. Proteomic approaches to tumor marker discovery[ J]. Arch Pathol Lab Meal, 2002, 126(12) : 1518.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部